Transabdominal Electrical Stimulation for Constipation
Primary Purpose
Constipation
Status
Completed
Phase
Phase 1
Locations
Study Type
Interventional
Intervention
Interferential Stimulation
TENS stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Constipation focused on measuring Constipation, Neuromodulation, Interferential, Transabdominal
Eligibility Criteria
Inclusion Criteria:
- Age over 18 years
- Rome III defined constipation (frequency of defecation of less than three times a week, straining or sense of incomplete emptying associated with at least 25% of defecations. Lumpy, hard stools or anal digitation for at least 25% of defecations
- Failed Biofeedback
- Competent and willing to complete stimulation at home
- Competent and willing to complete the questionnaires and bowel diaries
Exclusion Criteria:
- Rectal prolapse
- Active inflammatory bowel disease
- Pregnancy or intention to become pregnant during trial
- Spinal cord injuries/cauda equina syndrome
- Other implanted electrical devices
- Allergy to device components
- Neurological disorders
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Interferential Stimulation
Standard electrical stimulation
Arm Description
Medical Device: Interferential stimulation. Stimulation parameters: 4 KHz of carrier stimulation, beat frequency between 80-160Hz, amplitude upto 33mA. Delivered via two 100mm x 50mm adhesive pads placed on the anterior abdominal wall
Medical Device: Standard electrical stimulation. Parameters set to provide continuous electrical stimulation at a pulse width of 210µs and a frequency of 14Hz and an amplitude upto 33mA.
Outcomes
Primary Outcome Measures
Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL)
A validated tool for constipation severity assessment
Secondary Outcome Measures
Patient-Assessment of Constipation Symptoms (PAC-SYM)
A validated tool for constipation severity assessment
A bowel visual analogue scale
a bowel visual analogue scale (0-100 where 0= 'very unhappy' 100= 'very happy') based on patients' response to the question 'how happy are you with the way your bowel has been functioning'
Weekly bowel and laxative diary
Standard bowel and laxative diary
Full Information
NCT ID
NCT02941471
First Posted
October 18, 2016
Last Updated
October 20, 2016
Sponsor
St Mark's Hospital Foundation
1. Study Identification
Unique Protocol Identification Number
NCT02941471
Brief Title
Transabdominal Electrical Stimulation for Constipation
Official Title
A Double-blind Pilot Randomised Trial of Transabdominal Interferential Stimulation and Transcutaneous Electrical Nerve Stimulation for Severe Chronic Constipation in Adults Unresponsive to Conservative Treatments
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
November 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
St Mark's Hospital Foundation
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Several transabdominal electrical stimulation studies have been reported for constipation in childhood. This study aims to assess the efficacy of this technique in adults with chronic constipation and compare two different electrical therapies.
Detailed Description
Patients with Rome III defined constipation unresponsive to medical and behavioural treatment will be randomised in a double-blind prospective trial to receive either four weeks of transabdominal electrical stimulation (TENS) or Interferential stimulation (IFC). Treatment will be self-administered at home for sixty minutes a day. The response to treatment will be assessed with the Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL), the Patient-Assessment of Constipation Symptoms (PAC-SYM) tool and a bowel visual analogue scale (VAS). A bowel diary will be kept a week before and during the final week of stimulation, recording daily bowel frequency.
IFC stimulation is an effective, cheap and low risk intervention which has demonstrated efficacy for dysphagia, urinary incontinence, overactive bladder syndromes and chronic pain. The precise mechanism of its analgesic and pro-kinetic effect is unknown. The intervention is delivered by two separate continuous alternating electrical currents. Two pairs of pad electrodes are arranged in a quadripolar manner where each pair delivers a different frequency of current. It is suggested that this arrangement of stimulation improves colonic propagation. However as direct massage of the abdomen has demonstrated benefit in constipation it is argued that IFC is not a specific requirement and that non-IFC electrical stimulation over the abdomen is sufficient to evoke the same colonic and clinical responses. Owing to these questions the efficacy of this intervention will be further evaluated in adults.
This study has two aims. The primary aim is to evaluate the effectiveness of transabdominal electrical nerve stimulation (TENS) in adult patients with chronic constipation. The secondary aim is to establish whether IFC was superior to non-IFC (TENS) electrical stimulation in adults with chronic constipation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Constipation
Keywords
Constipation, Neuromodulation, Interferential, Transabdominal
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Interferential Stimulation
Arm Type
Experimental
Arm Description
Medical Device: Interferential stimulation. Stimulation parameters: 4 KHz of carrier stimulation, beat frequency between 80-160Hz, amplitude upto 33mA. Delivered via two 100mm x 50mm adhesive pads placed on the anterior abdominal wall
Arm Title
Standard electrical stimulation
Arm Type
Active Comparator
Arm Description
Medical Device: Standard electrical stimulation. Parameters set to provide continuous electrical stimulation at a pulse width of 210µs and a frequency of 14Hz and an amplitude upto 33mA.
Intervention Type
Device
Intervention Name(s)
Interferential Stimulation
Other Intervention Name(s)
NeuroTrac® IFC Rehab device (Verity Medical Ltd, UK).
Intervention Description
Transabdominal interferential electrcial stimulation
Intervention Type
Device
Intervention Name(s)
TENS stimulation
Other Intervention Name(s)
NeuroTrac® Continence device (Verity Medical Ltd, UK).
Intervention Description
Transabdominal standard electrical stimulation
Primary Outcome Measure Information:
Title
Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL)
Description
A validated tool for constipation severity assessment
Time Frame
After 4 weeks of stimulation
Secondary Outcome Measure Information:
Title
Patient-Assessment of Constipation Symptoms (PAC-SYM)
Description
A validated tool for constipation severity assessment
Time Frame
After 4 weeks of stimulation
Title
A bowel visual analogue scale
Description
a bowel visual analogue scale (0-100 where 0= 'very unhappy' 100= 'very happy') based on patients' response to the question 'how happy are you with the way your bowel has been functioning'
Time Frame
After 4 weeks of stimulation
Title
Weekly bowel and laxative diary
Description
Standard bowel and laxative diary
Time Frame
one week and 4 weeks of stimulation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age over 18 years
Rome III defined constipation (frequency of defecation of less than three times a week, straining or sense of incomplete emptying associated with at least 25% of defecations. Lumpy, hard stools or anal digitation for at least 25% of defecations
Failed Biofeedback
Competent and willing to complete stimulation at home
Competent and willing to complete the questionnaires and bowel diaries
Exclusion Criteria:
Rectal prolapse
Active inflammatory bowel disease
Pregnancy or intention to become pregnant during trial
Spinal cord injuries/cauda equina syndrome
Other implanted electrical devices
Allergy to device components
Neurological disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alan Warnes, PhD
Organizational Affiliation
The London Northwest Healthcare NHS Trust
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
Transabdominal Electrical Stimulation for Constipation
We'll reach out to this number within 24 hrs